Sep 28

PQA 03 - PQA 03: Digital Health Innovation and Informatics, Patient Safety & Quality, and Radiation and Cancer Biology

2622 - Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cell Lines Using a Rucaparib-Derived Auger-Emitting PARP1 Radioligand

10:45am - 12:00pm ET

Presenter(s)

Vladislav Sviderskiy, MD, PhD - Washington University School of Medicine in St. Louis, St. Louis, MO